Open-Label, Phase I, Pharmacokinetic Studies in Healthy Chinese Subjects to Evaluate the Bioequivalence and Food Effect of a Novel Formulation of Abiraterone Acetate Tablets

PURPOSE: Abiraterone acetate tablets (I)(N-AbA) is a novel tablet co-formulated with the absorption enhancer sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC). This study aimed to compare the pharmacokinetics, bioequivalence, safety, and food effects of N-AbA with the reference ZYTIGA(®) (R-AbA...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Zeying, Liu, Yaxin, Kuang, Yun, Yang, Shuang, Li, Jinlei, Ye, Ling, Huang, Jie, Pei, Qi, Huang, Yuanyuan, Yang, Guoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740623/
https://www.ncbi.nlm.nih.gov/pubmed/35018094
http://dx.doi.org/10.2147/DDDT.S339305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740623/
https://www.ncbi.nlm.nih.gov/pubmed/35018094
http://dx.doi.org/10.2147/DDDT.S339305

Ejemplares similares